What does the evidence say about Berberine Cardiometabolic Wellness Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Berberine Cardiometabolic Wellness Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Methodological quality was assessed with Cochrane RoB 2; certainty of evidence was rated using GRADE. [Epelde F (2025); evidence level 1] - These effects are clinically relevant and comparable to other nutraceuticals, although evidence remains limited by short trial duration and small sample sizes. [Epelde F (2025); evidence level 1] - Larger, long-term RCTs are warranted before turmeric can be recommended in evidence-based dyslipidemia guidelines. [Epelde F (2025); evidence level 1] - Background : Turmeric ( Curcuma longa ) and its main bioactive compound curcumin are widely promoted for cardiometabolic health, yet their efficacy on lipid parameters remains uncertain. [Epelde F (2025); evidence level 1] - MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) is a growing global concern. [Vrentzos E (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.